Skip to search formSkip to main contentSkip to account menu

Lymphoma, Primary Cutaneous Anaplastic Large Cell

Known as: Primary Anaplastic Large Cell Lymphoma of the Skin, Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma, Primary Cutaneous CD30 positive Large T Cell Lymphoma 
An anaplastic large cell lymphoma limited to the skin at the time of diagnosis. Most patients present with solitary or localized skin lesions, which… 
National Institutes of Health

Related topics

Related topics

28 relations
AnaplasiaAtypical lymphocyteHallmark CellHematopoietic and Lymphoid Cell

Narrower (1)

Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Current Risk Estimate of Breast Implant–Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants
Background: With breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) now accepted as a unique (iatrogenic… 
Highly Cited
2019
Highly Cited
2019
Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012–2018
Background: In January of 2011, the US Food and Drug Administration released a safety communication regarding the potential… 
Highly Cited
2017
Highly Cited
2017
Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Highly Cited
2011
Highly Cited
2011
Crizotinib in anaplastic large-cell lymphoma.
The anaplastic lymphoma kinase (ALK) inhibitor crizotinib has been shown to induce a response in lung cancers in which ALK is… 
Highly Cited
2011
Highly Cited
2011
Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study.
PURPOSE To evaluate risk factors for outcome in children and adolescents with relapse of anaplastic large-cell lymphoma (ALCL… 
Highly Cited
2010
Highly Cited
2010
Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
BACKGROUND Systemic sclerosis (SSc) has high mortality and morbidity. Current management focuses on early detection and treatment… 
Highly Cited
2005
Highly Cited
2005
Vibratory adaptation of cutaneous mechanoreceptive afferents.
The objective of this study was to investigate the effects of extended suprathreshold vibratory stimulation on the sensitivity of… 
Highly Cited
1999
Highly Cited
1999
Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.
Cutaneous marginal zone lymphoma (MZL) is a recently described low-grade B-cell lymphoma that usually follows an indolent course… 
Highly Cited
1996
Highly Cited
1996
Cutaneous adult myofibroma: a vascular neoplasm
Infantile myofibromatosis is a distinctive type of fibromatosis that usually develops during the immediate perinatal period… 
Highly Cited
1994
Highly Cited
1994
Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.
PURPOSE To prove prospectively the efficacy of a short-pulse chemotherapy for treatment of Ki-1 anaplastic large-cell lymphoma… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)